Condition: Bladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable · Upper Tract Urothelial Cancer · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
This study aims to prospectively observe whether certain alterations in some genes related to the DNA repair mechanism are related to better response to platinum-based chemotherapy used to treat metastatic bladder or urothelial cancers.
This description comes directly from the study's public registry record.
Roberto Iacovelli, Prof · +390630157373 · roberto.iacovelli@policlinicogemelli.it
Always discuss trial participation with your own doctor first.
| Fondazione Policlinico Universitario A. Gemelli IRCCS | Rome, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06820255